2 results
Approved WMOCompleted
· To determine therapeutic efficacy of Tracleer in patients with active Behcet disease. Furthermore:· To study cytokine and immunological patterns and ET-1levels in those patients.
Approved WMOCompleted
The objective of this trial is to demonstrate that bosentan delays disease worsening or death in patients with IPF.